Biologic, demographic, and social factors affecting triple negative breast cancer outcomes.
暂无分享,去创建一个
[1] T. Kolevska,et al. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting. , 2013, Journal of oncology practice.
[2] E. Fisher,et al. Coaching intervention as a strategy for minority recruitment to cancer clinical trials. , 2013, Journal of oncology practice.
[3] L. Siminoff,et al. Perceptions of participation in a phase I, II, or III clinical trial among African American patients with cancer: what do refusers say? , 2013, Journal of oncology practice.
[4] W. McCaskill-Stevens,et al. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. , 2013, Journal of oncology practice.
[5] M. Knobf,et al. Being prepared: essential to self-care and quality of life for the person with cancer. , 2013, Clinical journal of oncology nursing.
[6] K. Hess,et al. The prognostic impact of age in patients with triple-negative breast cancer , 2013, Breast Cancer Research and Treatment.
[7] D. Yardley,et al. Updates in the treatment of basal/triple-negative breast cancer , 2013, Current Opinion in Obstetrics and Gynecology.
[8] K. Pogoda,et al. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients , 2013, Medical Oncology.
[9] G. Guler,et al. Lymphatic and Capillary Invasion Patterns in Triple Negative Breast Cancer , 2012, The American surgeon.
[10] P. Neven,et al. Update on triple-negative breast cancer: prognosis and management strategies , 2012, International journal of women's health.
[11] C. Sotiriou,et al. Understanding the biology of triple-negative breast cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] J. Crown,et al. Emerging targeted therapies in triple-negative breast cancer. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] M. Echenique,et al. Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto Rico. , 2012, Puerto Rico health sciences journal.
[14] Paul Ellis,et al. Dissecting the heterogeneity of triple-negative breast cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Salner,et al. Needs assessment of cancer survivors in Connecticut , 2012, Journal of Cancer Survivorship.
[16] P. O'Brien,et al. Obstacles to participation in randomised cancer clinical trials: A systematic review of the literature , 2012, Journal of medical imaging and radiation oncology.
[17] Xi Chen,et al. TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer , 2012, Cancer informatics.
[18] A. González-Angulo,et al. Triple‐negative breast cancer in Hispanic patients , 2011, Cancer.
[19] A. Richardson,et al. The experiences, needs and concerns of younger women with breast cancer: a meta‐ethnography , 2011, Psycho-oncology.
[20] X. Chen,et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.
[21] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[22] L. Newman,et al. Higher population‐based incidence rates of triple‐negative breast cancer among young African‐American women , 2011, Cancer.
[23] A. Kurian,et al. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups , 2010, Breast Cancer Research.
[24] L. Newman,et al. African ancestry and higher prevalence of triple‐negative breast cancer , 2010, Cancer.
[25] R. Chacón,et al. Triple-negative breast cancer , 2010, Breast Cancer Research.
[26] B. Pockaj,et al. Triple-Negative Breast Cancers: Unique Clinical Presentations and Outcomes , 2010, Annals of Surgical Oncology.
[27] Scott D Ramsey,et al. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. , 2010, Journal of the National Cancer Institute.
[28] Harold L. Moses,et al. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program , 2010 .
[29] R. Shi,et al. Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients. , 2010, Breast.
[30] E. Garrett-Mayer,et al. Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status , 2010, Cancer Causes & Control.
[31] B. Polite,et al. Triple-Negative Breast Cancers: A View From 10,000 Feet , 2010, Cancer journal.
[32] Seema A Khan,et al. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[33] C. Perou,et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] O. Dizdar,et al. Pharmacotherapy of triple-negative breast cancer , 2009, Expert opinion on pharmacotherapy.
[35] R. Coates,et al. The epidemiology of triple-negative breast cancer, including race , 2009, Cancer Causes & Control.
[36] T. Lash,et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index , 2009, Breast Cancer Research.
[37] C. Perou,et al. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] Linda G. Kimmel,et al. Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. , 2009, Journal of oncology practice.
[39] L. Esserman,et al. Hypertension is an independent predictor of survival disparity between African‐American and white breast cancer patients , 2009, International journal of cancer.
[40] G. Hobbs,et al. Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population , 2008, Cancer Epidemiology Biomarkers & Prevention.
[41] G. Hortobagyi,et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women , 2008, Breast Cancer Research and Treatment.
[42] T. Naab,et al. Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women. , 2008, American journal of surgery.
[43] Lyndsay N Harris,et al. Triple negative breast cancer: current understanding of biology and treatment options , 2008, Current opinion in obstetrics & gynecology.
[44] Richard L. Street,et al. Patient-centered communication in cancer care: Promoting healing and reducing suffering , 2007 .
[45] Suzanne M. Miller,et al. Barriers to clinical trial participation as perceived by oncologists and patients. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.
[46] S. Narod,et al. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence , 2007, Clinical Cancer Research.
[47] D. Schrag,et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] M. Knobf,et al. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors. , 2006, The oncologist.
[49] Kumanan Wilson,et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. , 2006, The Lancet. Oncology.
[50] A. Neugut,et al. Racial disparities in treatment and survival among women with early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] S. Kasl,et al. Inadequate Follow-up of Abnormal Screening Mammograms: Findings From the Race Differences in Screening Mammography Process Study (United States) , 2005, Cancer Causes & Control.
[52] B. Falkner,et al. Race/ethnic issues in obesity and obesity-related comorbidities. , 2004, The Journal of clinical endocrinology and metabolism.
[53] P. Ganz,et al. Breast cancer in younger women: reproductive and late health effects of treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] V. Parker,et al. Inner resources as predictors of psychological well-being in middle-income african american breast cancer survivors. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[55] M. Wilmoth,et al. Accept me for myself: African American women's issues after breast cancer. , 2001, Oncology nursing forum.
[56] N. Lackey,et al. African American women's experiences with the initial discovery, diagnosis, and treatment of breast cancer. , 2001, Oncology nursing forum.
[57] M. Coovert,et al. Strategic physician communication and oncology clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[59] P. Fumoleau,et al. The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment , 2012, The breast journal.
[60] C. Hudis,et al. Triple-negative breast cancer: an unmet medical need. , 2011, The oncologist.
[61] M. Roizen. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients , 2010 .
[62] R. Coates,et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA , 2008, Breast Cancer Research and Treatment.
[63] B. Davis,et al. African American women coping with breast cancer: a qualitative analysis. , 2003, Oncology nursing forum.
[64] R. Carlson. NCCN breast cancer clinical practice guidelines in oncology: an update. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.